is exondys 51 gene therapy?
By modulating genetic expression, both treatments stimulate production of a key muscle-building protein called dystrophin that is absent in DMD patients. Exondys 51 won accelerated approval on data from a trial that did not include traditional placebo controls, and Vyondys 53's application was poised to do the same.